Literature DB >> 28893915

Hyperbiofilm Formation by Bordetella pertussis Strains Correlates with Enhanced Virulence Traits.

Natalia Cattelan1, Jamie Jennings-Gee2, Purnima Dubey3,4, Osvaldo M Yantorno5, Rajendar Deora6,4.   

Abstract

Pertussis, or whooping cough, caused by the obligate human pathogen Bordetella pertussis is undergoing a worldwide resurgence. The majority of studies of this pathogen are conducted with laboratory-adapted strains which may not be representative of the species as a whole. Biofilm formation by B. pertussis plays an important role in pathogenesis. We conducted a side-by-side comparison of the biofilm-forming abilities of the prototype laboratory strains and the currently circulating isolates from two countries with different vaccination programs. Compared to the reference strain, all strains examined herein formed biofilms at high levels. Biofilm structural analyses revealed country-specific differences, with strains from the United States forming more structured biofilms. Bacterial hyperaggregation and reciprocal expression of biofilm-promoting and -inhibitory factors were observed in clinical isolates. An association of increased biofilm formation with augmented epithelial cell adhesion and higher levels of bacterial colonization in the mouse nose and trachea was detected. To our knowledge, this work links for the first time increased biofilm formation in bacteria with a colonization advantage in an animal model. We propose that the enhanced biofilm-forming capacity of currently circulating strains contributes to their persistence, transmission, and continued circulation.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Bordetella pertussis; biofilms; hyperbiofilm; virulence

Mesh:

Year:  2017        PMID: 28893915      PMCID: PMC5695122          DOI: 10.1128/IAI.00373-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  73 in total

Review 1.  Bacterial biofilms: an emerging link to disease pathogenesis.

Authors:  Matthew R Parsek; Pradeep K Singh
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

2.  Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.

Authors:  N Hegerle; A-S Paris; D Brun; G Dore; E Njamkepo; S Guillot; N Guiso
Journal:  Clin Microbiol Infect       Date:  2012-06-21       Impact factor: 8.067

3.  Automated tool for the detection of cell nuclei in digital microscopic images: application to retinal images.

Authors:  Jiyun Byun; Mark R Verardo; Baris Sumengen; Geoffrey P Lewis; B S Manjunath; Steven K Fisher
Journal:  Mol Vis       Date:  2006-08-16       Impact factor: 2.367

4.  Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?

Authors:  Valérie Caro; Valérie Bouchez; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

5.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; G Broitman-Maduro; G Dean; S Newman; M Peppler; A A Weiss
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Magnesium limitation is an environmental trigger of the Pseudomonas aeruginosa biofilm lifestyle.

Authors:  Heidi Mulcahy; Shawn Lewenza
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  Genome Sequences of 28 Bordetella pertussis U.S. Outbreak Strains Dating from 2010 to 2012.

Authors:  Eric T Harvill; Laura L Goodfield; Yury Ivanov; Jessica A Meyer; Christopher Newth; Pamela Cassiday; Maria Lucia Tondella; Patty Liao; Jerry Zimmerman; Kathleen Meert; David Wessel; John Berger; J Michael Dean; Richard Holubkov; Jeri Burr; Teresa Liu; Lauren Brinkac; Maria Kim; Liliana Losada
Journal:  Genome Announc       Date:  2013-12-19

9.  Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni.

Authors:  Reuben Ha; Emilisa Frirdich; David Sychantha; Jacob Biboy; Michael E Taveirne; Jeremiah G Johnson; Victor J DiRita; Waldemar Vollmer; Anthony J Clarke; Erin C Gaynor
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

10.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more
  11 in total

1.  Continuous nondestructive monitoring of Bordetella pertussis biofilms by Fourier transform infrared spectroscopy and other corroborative techniques.

Authors:  Diego Serra; Alejandra Bosch; Daniela M Russo; María E Rodríguez; Angeles Zorreguieta; Juergen Schmitt; Dieter Naumann; Osvaldo Yantorno
Journal:  Anal Bioanal Chem       Date:  2007-01-10       Impact factor: 4.142

Review 2.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

3.  Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice.

Authors:  Kyle Caution; Kacy Yount; Rajendar Deora; Purnima Dubey
Journal:  J Vis Exp       Date:  2019-02-22       Impact factor: 1.355

4.  Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine.

Authors:  Peng Wang; Chang-Xin Huo; Shuyao Lang; Kyle Caution; Setare Tahmasebi Nick; Purnima Dubey; Rajendar Deora; Xuefei Huang
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-25       Impact factor: 15.336

5.  PgaB orthologues contain a glycoside hydrolase domain that cleaves deacetylated poly-β(1,6)-N-acetylglucosamine and can disrupt bacterial biofilms.

Authors:  Dustin J Little; Roland Pfoh; François Le Mauff; Natalie C Bamford; Christina Notte; Perrin Baker; Manita Guragain; Howard Robinson; Gerald B Pier; Mark Nitz; Rajendar Deora; Donald C Sheppard; P Lynne Howell
Journal:  PLoS Pathog       Date:  2018-04-23       Impact factor: 6.823

Review 6.  Bacterial Biofilm and its Role in the Pathogenesis of Disease.

Authors:  Lene K Vestby; Torstein Grønseth; Roger Simm; Live L Nesse
Journal:  Antibiotics (Basel)       Date:  2020-02-03

7.  Structural mechanism for regulation of DNA binding of BpsR, a Bordetella regulator of biofilm formation, by 6-hydroxynicotinic acid.

Authors:  William T Booth; Ryan R Davis; Rajendar Deora; Thomas Hollis
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

8.  A Mutation Upstream of the rplN-rpsD Ribosomal Operon Downregulates Bordetella pertussis Virulence Factor Production without Compromising Bacterial Survival within Human Macrophages.

Authors:  Jakub Novák; David Jurnečka; Irena Linhartová; Jana Holubová; Ondřej Staněk; Daniel Štipl; Ana Dienstbier; Branislav Večerek; Nayara Azevedo; Jan Provazník; Vladimír Beneš; Peter Šebo
Journal:  mSystems       Date:  2020-12-08       Impact factor: 6.496

9.  Structural Analysis of Bordetella pertussis Biofilms by Confocal Laser Scanning Microscopy

Authors:  Natalia Cattelan; Osvaldo Miguel Yantorno; Rajendar Deora
Journal:  Bio Protoc       Date:  2018-08-05

10.  Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Authors:  Francisco Carriquiriborde; Pablo Martin Aispuro; Nicolás Ambrosis; Eugenia Zurita; Daniela Bottero; María Emilia Gaillard; Celina Castuma; Erika Rudi; Aníbal Lodeiro; Daniela F Hozbor
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.